Caprolactam Chemicals Limited / Fundamentals
Income statement
- Net revenue
€641.04K - Cost of goods sold
€124.91K - Gross profit
€516.14K - SG&A expenses
€10.21K - R&D expenses
€0.00 - EBITDA
€195.73K - D&A
€155.33K - EBIT
€39.63K - Interest expenses
€55.91K - EBT
-€15.51K - Tax expenses
-€1.45K - Net income
-€13.73K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€13.73K - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€0.00 - Cash and short-term investments
€8.45K - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
-€8.45K - Total current assets
€0.00 - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€0.00 - Total assets
€0.00 - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€0.00 - Total current liabilities
€0.00 - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
-€519.34K - Total non-current liabilities
-€519.34K - Total liabilities
-€519.34K - Common stock
€0.00 - Retained earnings
€0.00 - Other equity
€519.34K - Total equity
€519.34K - Total liabilities and shareholders' equity
€0.00
Company information
- Market capitalization
€1.81M - Employees
0 - Enterprise Value
€253.76M
Company ratios
- Gross margin
-
80.5% - EBITDA margin
-
30.5% - EBIT margin
-
6.2% - EBT margin
-
-2.4% - Net margin
-
-2.1% - ROE
-
-2.6% - ROA
-
0.0% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
69.5% - Net sales per employee
-
€0.00 - Net income per employee
-
€0.00